GO
Loading...
 

Allergan CEO: FDA Voted In Favor of Voluma

Thu 02 May 13 | 06:15 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Allergan CEO: FDA Voted In Favor of Voluma

Thu 02 May 13 | 06:15 PM ET
Allergan reported positive earnings on Wednesday, but the stock tumbled after. Its CEO David Pyott discusses earnings, drug delays and the future of the company.
 
RELATED ARTICLES AND CONTENT
More Videos
Go
Displaying results for: Latest Video | US